Dr. Hay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2973 12th St SE
Salem, OR 97302Phone+1 503-561-7100Fax+1 503-561-7124
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Urology, 1985 - 1989- Stanford Health Care-Sponsored Stanford UniversityResidency, Surgery, 1983 - 1985
Johns Hopkins University School of MedicineClass of 1983
Certifications & Licensure
CA State Medical License 1985 - Present
OR State Medical License 1989 - 2025
WA State Medical License 2020 - 2025
AK State Medical License 2018 - 2021- American Board of Urology Urology
Awards, Honors, & Recognition
- Member American Board of Urology
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 1 citationsFexapotide triflutate vs oral pharmacotherapy as initial therapy for moderate-to-severe benign prostate hyperplasia patients: a cost-effectiveness analysis.Yifan Wei, Joel W Hay, Alan R Hay, Sze-Chuan Suen
BMC Urology. 2022-05-13 - 2 citationsProspective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results.Neal D. Shore, Steven A. Kaplan, Ronald F. Tutrone, Richard Levin, James Bailen
World Journal of Urology. 2020-02-22 - 11 citationsFexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement.Neal D. Shore, Ronald F. Tutrone, Mitchell Efros, Mohamed Bidair, Barton Wachs
World Journal of Urology. 2018-01-29
Press Mentions
Nymox Provides Update on Current Corporate Activities and MilestonesJanuary 28th, 2020
Nymox Announces New Peer Review Article on Fexapotide Pharmaco-Ablation Experimental Studies Published in Research and Reports in UrologyJanuary 6th, 2020
New Online Commentary in UroToday on Fexapotide BPH Clinical Trial Results Publication in World Journal of UrologyApril 10th, 2018- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
